Free Trial

Bioventus (BVS) Institutional Ownership

Bioventus logo
$13.39 -0.17 (-1.26%)
As of 12:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Bioventus (NASDAQ:BVS)

Current
Institutional Ownership
Percentage
62.94%
Number of
Institutional Buyers
(last 12 months)
68
Total
Institutional Inflows
(last 12 months)
$50.91M
Number of
Institutional Sellers
(last 12 months)
32
Total
Institutional Outflows
(last 12 months)
$15.38M
Get BVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bioventus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BVS Institutional Buying and Selling by Quarter

Bioventus Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Squarepoint Ops LLC269,267$2.54M0.0%+21.9%0.320%
8/13/2026Globeflex Capital L P165,865$1.57M0.2%N/A0.199%
8/6/2026Bank of New York Mellon Corp152,316$1.44M0.0%N/A0.182%
7/10/2026Wedge Capital Management L L P NC215,051$2.03M0.0%-11.1%0.257%
5/19/2026Bank of America Corp DE86,057$786K0.0%+40.3%0.103%
5/18/2026Engine Capital Management LP315,018$2.88M0.3%N/A0.377%
5/18/2026Eversept Partners LP159,110$1.45M0.1%-66.2%0.190%
5/16/2026The Manufacturers Life Insurance Company13,569$124K0.0%-11.8%0.016%
5/16/2026Quantinno Capital Management LP72,023$658K0.0%+119.6%0.086%
5/16/2026Lazard Asset Management LLC305,517$2.79M0.0%+12.9%0.366%
5/14/2026Renaissance Technologies LLC489,460$4.47M0.0%-20.4%0.586%
5/14/2026Sei Investments Co.289,648$2.64M0.0%+160.7%0.348%
5/14/2026Globeflex Capital L P123,052$1.12M0.2%+59.6%0.148%
5/14/2026State of Wyoming35,530$324K0.0%-7.4%0.043%
5/7/2026Dimensional Fund Advisors LP873,138$7.97M0.0%+14.1%1.050%
5/6/2026Allspring Global Investments Holdings LLC79,913$730K0.0%+11.5%0.096%
5/5/2026Bank of New York Mellon Corp143,909$1.31M0.0%-4.1%0.173%
5/5/2026Hillsdale Investment Management Inc.671,139$6.13M0.2%+148.7%0.807%
5/1/2026Fifth Third Bancorp161,926$1.48M0.0%N/A0.195%
4/23/2026Inspire Investing LLC182,918$1.67M0.1%N/A0.220%
4/21/2026Wesbanco Bank Inc.98,000$895K0.0%N/A0.118%
4/16/2026Diversified Trust Co10,975$100K0.0%N/A0.013%
3/9/2026Corient Private Wealth LLC19,471$145K0.0%+44.9%0.024%
3/3/2026Caitong International Asset Management Co. Ltd5,522$41K0.0%+17,156.3%0.007%
2/24/2026Anderson Financial Strategies LLC213,208$1.59M0.9%+58.3%0.258%
2/19/2026Invesco Ltd.33,621$250K0.0%+52.9%0.041%
2/19/2026Corient Private Wealth LLC19,471$145K0.0%+44.9%0.024%
2/18/2026Mercer Global Advisors Inc. ADV13,529$101K0.0%+16.2%0.016%
2/18/2026EP Wealth Advisors LLC18,193$135K0.0%N/A0.022%
2/18/2026XTX Topco Ltd45,990$342K0.0%-35.1%0.056%
2/18/2026Tudor Investment Corp ET AL46,682$347K0.0%N/A0.056%
2/18/2026Millennium Management LLC59,422$442K0.0%-202.3%0.072%
2/18/2026Engineers Gate Manager LP68,889$513K0.0%+6.0%0.083%
2/18/2026Eversept Partners LP471,257$3.51M0.2%+8.6%0.569%
2/18/2026Balyasny Asset Management L.P.18,667$139K0.0%N/A0.023%
2/18/2026Boothbay Fund Management LLC59,705$444K0.0%-48.9%0.072%
2/17/2026AQR Capital Management LLC446,757$3.32M0.0%+14.5%0.540%
2/17/2026Lazard Asset Management LLC270,509$2.01M0.0%+101.7%0.327%
2/17/2026Trexquant Investment LP131,848$981K0.0%+397.9%0.159%
2/17/2026ExodusPoint Capital Management LP44,907$334K0.0%N/A0.054%
The Midwestern Disruptor Big Pharma Doesn’t Want You to Know About (Ad)

A little-known Midwestern firm sits at the center of what the Wall Street Journal calls medicine's biggest moment since antibiotics. It does not invent drugs or hold blockbuster patents. McKinsey calls the shift a game changer, and the International Journal of Surgery describes it as a revolutionary path forward. Yet this company remains largely overlooked by investors. See the full research on this emerging healthcare story now.tc pixel

See the full research on this emerging healthcare story now
2/17/2026Meros Investment Management LP315,160$2.35M0.9%N/A0.381%
2/16/2026Squarepoint Ops LLC191,173$1.42M0.0%+29.5%0.231%
2/16/2026Panagora Asset Management Inc.178,064$1.33M0.0%-45.2%0.215%
2/16/2026Mariner LLC160,312$1.19M0.0%-1.4%0.194%
2/16/2026Barclays PLC92,523$688K0.0%+40.2%0.112%
2/13/2026Nantahala Capital Management LLC6,047,403$44.99M1.5%+4.1%7.307%
2/13/2026Marshall Wace LLP288,900$2.15M0.0%+0.4%0.349%
2/13/2026Essex Investment Management Co. LLC387,886$2.89M0.4%N/A0.469%
2/13/2026Charles Schwab Investment Management Inc.375,173$2.79M0.0%-16.1%0.453%
2/13/2026State Street Corp891,024$6.63M0.0%+1.7%1.077%
2/13/2026Wells Fargo & Company MN50,634$377K0.0%+74.2%0.061%
2/12/2026Jane Street Group LLC269,252$2.00M0.0%-2.1%0.325%
2/12/2026HRT Financial LP130,649$972K0.0%N/A0.158%
2/12/2026Brooklyn Investment Group12,049$91K0.0%N/A0.015%
2/12/2026Tocqueville Asset Management L.P.330,000$2.46M0.0%+8.2%0.399%
2/12/2026Renaissance Technologies LLC615,100$4.58M0.0%-24.2%0.743%
2/12/2026Dimensional Fund Advisors LP765,208$5.69M0.0%+2.9%0.925%
2/12/2026EntryPoint Capital LLC23,428$174K0.1%N/A0.028%
2/12/2026Campbell & CO Investment Adviser LLC14,305$106K0.0%-47.1%0.017%
2/11/2026Deutsche Bank AG25,138$187K0.0%+8.2%0.030%
2/11/2026Franklin Resources Inc.55,133$410K0.0%-45.8%0.067%
2/11/2026O Shaughnessy Asset Management LLC13,303$99K0.0%N/A0.016%
2/11/2026Los Angeles Capital Management LLC67,968$460K0.0%-4.1%0.082%
2/11/2026State of Wyoming38,357$285K0.0%+45.5%0.046%
2/10/2026Goldman Sachs Group Inc.369,818$2.75M0.0%-5.8%0.447%
2/10/2026Hillsdale Investment Management Inc.269,909$2.01M0.1%N/A0.326%
2/10/2026Intech Investment Management LLC28,234$210K0.0%-12.8%0.034%
2/9/2026Geode Capital Management LLC1,120,238$8.34M0.0%+1.8%1.354%
2/9/2026Knights of Columbus Asset Advisors LLC290,285$2.16M0.1%-3.2%0.351%
2/9/2026Royce & Associates LP1,251,282$9.31M0.1%-0.9%1.512%
2/6/2026Legato Capital Management LLC137,562$1.02M0.1%+1,042.8%0.166%
2/6/2026Covestor Ltd6,445$48K0.0%-35.2%0.008%
2/2/2026Truist Financial Corp12,480$93K0.0%N/A0.015%
1/15/2026Allspring Global Investments Holdings LLC71,688$533K0.0%+9.6%0.087%
1/9/2026SG Americas Securities LLC10,792$80K0.0%N/A0.013%
1/1/2026JPMorgan Chase & Co.114,777$768K0.0%-52.9%0.139%
11/17/2025Jacobs Levy Equity Management Inc.140,967$943K0.0%+3.4%0.170%
11/17/2025PharVision Advisers LLC15,302$102K0.1%+51.9%0.018%
11/17/2025Verition Fund Management LLC26,224$175K0.0%-41.0%0.032%
11/17/2025Sherbrooke Park Advisers LLC14,363$96K0.0%N/A0.017%
11/17/2025Qube Research & Technologies Ltd525,103$3.51M0.0%+25.4%0.634%
11/17/2025Prelude Capital Management LLC10,990$74K0.0%N/A0.013%
11/17/2025Nantahala Capital Management LLC5,810,662$38.87M1.4%+10.0%7.021%
11/17/2025Mariner LLC162,556$1.09M0.0%+6.8%0.196%
11/17/2025Mercer Global Advisors Inc. ADV11,642$78K0.0%N/A0.014%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,700$145K0.0%-14.0%0.026%
11/17/2025Divisadero Street Capital Management LP695,517$4.65M0.2%-35.6%0.840%
11/17/2025Bank of America Corp DE32,390$217K0.0%-21.4%0.039%
11/17/2025Boothbay Fund Management LLC116,854$782K0.0%+39.5%0.141%
11/17/2025Aquatic Capital Management LLC24,614$165K0.0%+7,427.2%0.030%
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel

Watch the video to learn how this plan could affect you
11/17/2025Algert Global LLC24,700$165K0.0%-79.2%0.030%
11/14/2025Lazard Asset Management LLC134,121$897K0.0%+79.0%0.162%
11/14/2025Zacks Investment Management51,412$344K0.0%-8.2%0.062%
11/14/2025Two Sigma Investments LP205,026$1.37M0.0%N/A0.248%
11/14/2025Squarepoint Ops LLC147,680$988K0.0%+36.7%0.179%
11/14/2025Diker Management LLC25,000$167K0.1%N/A0.030%
11/13/2025Kennedy Capital Management LLC461,579$3.09M0.1%+219.6%0.558%
11/13/2025Tocqueville Asset Management L.P.305,000$2.04M0.0%+29.8%0.369%
11/13/2025BNP Paribas Financial Markets248,539$1.66M0.0%+76.8%0.301%
11/13/2025Franklin Resources Inc.101,786$681K0.0%-22.4%0.123%


BVS Institutional Ownership - Frequently Asked Questions

During the previous two years, 160 institutional investors and hedge funds held shares of Bioventus. The most heavily invested institutionals were Nantahala Capital Management LLC ($44.99M), Vanguard Group Inc. ($19.57M), Driehaus Capital Management LLC ($13.22M), Royce & Associates LP ($9.31M), Geode Capital Management LLC ($8.34M), Nuveen Asset Management LLC ($8.21M), and Dimensional Fund Advisors LP ($7.97M).Learn more on Bioventus' institutional investors.

62.94% of Bioventus' stock is owned by institutional investors. Learn more on BVS's institutional investor holdings.

Of the 139 institutional investors that purchased Bioventus' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($2.02M), Royce & Associates LP ($1.06M), Hillsdale Investment Management Inc. ($671.14K), Segall Bryant & Hamill LLC ($610.13K), Driehaus Capital Management LLC ($607.74K), Vanguard Group Inc. ($603.07K), and Nuveen LLC ($513.62K).

Institutional investors have bought a total of 6,599,652 shares in the last 24 months. This purchase volume represents approximately $50.91M in transactions.

Of the 32 institutional investors that sold Bioventus' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Divisadero Street Capital Management LP ($385.12K), Renaissance Technologies LLC ($321.74K), Eversept Partners LP ($312.15K), JPMorgan Chase & Co. ($257.87K), Panagora Asset Management Inc. ($147.14K), Algert Global LLC ($94.29K), and Franklin Resources Inc. ($76.02K).

Institutional investors have sold a total of 2,055,432 shares in the last 24 months. This volume of shares sold represents approximately $15.38M in transactions.



Institutional ownership data for NASDAQ:BVS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners